BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4606249)

  • 1. Assessment of the biologic availability of digoxin in man.
    Fleckenstein L; Kroening B; Weintraub M
    Clin Pharmacol Ther; 1974 Sep; 16(3):435-43. PubMed ID: 4606249
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
    Shaw TR; Raymond K; Howard MR; Hamer J
    Br Med J; 1973 Dec; 4(5895):763-6. PubMed ID: 4758573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of digoxin in plasma and urine in neonates, infants, and children with heart disease.
    Wettrell G; Andersson KE; Bertler A; Lundström NR
    Acta Paediatr Scand; 1974 Sep; 63(5):705-10. PubMed ID: 4412576
    [No Abstract]   [Full Text] [Related]  

  • 4. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in biologic availability of digoxin from four preparations.
    Lindenbaum J; Mellow MH; Blackstone MO; Butler VP
    N Engl J Med; 1971 Dec; 285(24):1344-7. PubMed ID: 5121186
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood digoxin level and digitalization].
    Chavaz A; Balant L; Fabre J
    Schweiz Med Wochenschr; 1974 Jan; 104(3):65-74. PubMed ID: 4810264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
    Ochs H; Bodem G; Hahn E; Dengler HJ
    Klin Wochenschr; 1975 May; 53(9):425-9. PubMed ID: 1152354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin tablet bioavailability: single-dose and steady-state assessment.
    Preibisz JJ; Butler VP; Lindenbaum J
    Ann Intern Med; 1974 Oct; 81(4):469-74. PubMed ID: 4412826
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of different lots of digoxin tablets from the same manufacturer.
    Lindenbaum J
    Clin Pharmacol Ther; 1975 Mar; 17(3):296-301. PubMed ID: 1091397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels.
    Joubert PH; Müller FO; Pansegrouw DF
    S Afr Med J; 1974 May; 48(21):907-9. PubMed ID: 4834608
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Sep; 16(3):444-8. PubMed ID: 4412196
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioactive immunoassay of digoxin during digitalis therapy (author's transl)].
    Gobbi A; Limido A; Chiodini E
    G Ital Cardiol; 1976; 6(2):356-61. PubMed ID: 1010188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of digoxin bioavailability in single-dose studies.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum digoxin levels using an 125I-labelled antigen: Validation of method and observations on cardiac patients.
    Taubert K; Shapiro W
    Am Heart J; 1975 Jan; 89(1):79-86. PubMed ID: 1109556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Feb; 1(7902):343. PubMed ID: 46493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.